Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)

被引:12
|
作者
Bahri, Racha [1 ,2 ,3 ]
Boyer, Francois [2 ,3 ]
Halabi, Mohamad Adnan [1 ]
Chaunavel, Alain [4 ]
Feuillard, Jean [2 ,3 ,5 ]
Jaccard, Arnaud [2 ,3 ,6 ]
Ranger-Rogez, Sylvie [1 ,2 ,3 ,7 ]
机构
[1] Fac Pharm, Microbiol Dept, F-87025 Limoges, France
[2] CNRS Ctr Natl Rech Sci 7276, Unite Mixte Rech, F-87025 Limoges, France
[3] INSERM, U1262, F-87025 Limoges, France
[4] Univ Hosp Dupuytren, Pathol Dept, F-87000 Limoges, France
[5] Univ Hosp Dupuytren, Biol Hematol Dept, F-87000 Limoges, France
[6] Univ Hosp Dupuytren, Clin Hematol Dept, F-87042 Limoges, France
[7] Univ Hosp Dupuytren, Virol Dept, F-87000 Limoges, France
关键词
angioimmunoblastic T cell lymphoma; AITL; Epstein-Barr virus; EBV; clonal; latent; NGS; B-CELL; SEQUENCE; GENOME; TUMOR; DIVERSITY; ALIGNMENT; LYMPHADENOPATHY; IMMUNOGLOBULIN; PATTERNS; TISSUE;
D O I
10.3390/cancers14122899
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Angioimmunoblastic T cell lymphoma (AITL) is the most common peripheral T cell lymphoma encountered in Europe. It is a non-Hodgkin's lymphoma with a poor prognosis. The Epstein-Barr virus (EBV) virus is detected in more than 90% of biopsies, especially in large B lymphocytes. To date, the role of EBV in this pathology is still debated. The aim of our study was to analyze whole viral genomes in AITL compared to other EBV-associated lymphomas. We observed that two viral strains were mainly found in AITL, one of which appeared to be associated with poor post-diagnosis survival. Furthermore, the virus was found to be clonal and latent in all cases of AITL; for one biopsy, the virus was both latent and most likely replicative, depending on the cells. On the whole, these results support a role for EBV in AITL. The Epstein-Barr virus (EBV) is associated with angioimmunoblastic T cell lymphoma (AITL), a peripheral T lymphoma of poor prognosis in at least 90% of cases. The role of EBV in this pathology is unknown. Using next-generation sequencing, we sequenced the entire EBV genome in biopsies from 18 patients with AITL, 16 patients with another EBV-associated lymphoma, and 2 controls. We chose an EBV target capture method, given the high specificity of this technique, followed by a second capture to increase sensitivity. We identified two main viral strains in AITL, one of them associated with the mutations BNRF1 S542N and BZLF1 A206S and with mutations in the EBNA-3 and LMP-2 genes. This strain was characterized in patients with short post-diagnosis survival. The main mutations found during AITL on the most mutated latency or tegument genes were identified and discussed. We showed that the virus was clonal in all the AITL samples, suggesting that it may be involved in this pathology. Additionally, EBV was latent in all the AITL samples; for one sample only, the virus was found to be latent and probably replicative, depending on the cells. These various elements support the role of EBV in AITL.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Epstein-Barr virus positive diffuse large B-cell lymphoma transformed into angioimmunoblastic T-cell lymphoma after treatment
    Wang, Chaoyu
    Gong, Yi
    Jiang, Qingming
    Liang, Xiping
    Chen, Rui
    CLINICAL CASE REPORTS, 2021, 9 (05):
  • [42] Bortezomib is a novel inducer of latent Epstein Barr Virus (EBV) in EBV plus lymphoma cell lines.
    Kaluza, Vesna
    Braun, Helen
    Calimlim, Jeffrey
    Sun, Ren
    Said, Jonathan
    De Vos, Sven
    BLOOD, 2006, 108 (11) : 711A - 711A
  • [43] A Case of Cutaneous Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma in an Angioimmunoblastic T-Cell Lymphoma
    Lee, Mi-Hye
    Moon, Ik-Jun
    Lee, Woo-Jin
    Won, Chong-Hyun
    Chang, Sung-Eun
    Choi, Jee-Ho
    Lee, Mi-Woo
    ANNALS OF DERMATOLOGY, 2016, 28 (06) : 789 - 791
  • [44] Banked Epstein-Barr virus specific T-cells for treatment of EBV plus lymphoma
    Rouce, Rayne H.
    Perna, Serena K.
    Vyas, Gayatri
    Sharma, Sandhya
    Lapteva, Natalia
    Leen, Ann
    Rooney, Cliona M.
    Heslop, Helen E.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [45] Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic T cell lymphoma
    Bräuninger, A
    Spieker, T
    Willenbrock, K
    Gaulard, P
    Wacker, HH
    Rajewsky, K
    Hansmann, ML
    Küppers, R
    JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (07): : 927 - 940
  • [46] A RARE PRESENTATION OF ANGIOIMMUNOBLASTIC T CELL LYMPHOMA (AITL)
    Chams, Nour
    Chams, Sana
    Zakaria, Khalid
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S435 - S435
  • [47] Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain
    Trivedi, P
    Spinsanti, P
    Cuomo, L
    Volpe, M
    Takada, K
    Frati, L
    Faggioni, A
    JOURNAL OF VIROLOGY, 2001, 75 (10) : 4929 - 4935
  • [48] Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified
    Zettl, A
    Lee, SS
    Rüdiger, T
    Starostik, P
    Marino, M
    Kirchner, T
    Ott, M
    Müller-Hermelink, HK
    Ott, G
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 117 (03) : 368 - 379
  • [49] EPSTEIN-BARR VIRUS (EBV) NEGATIVE HUMAN MALIGNANT T LYMPHOCYTE CELL LINES
    KAPLAN, J
    SHOPE, TC
    PETERSON, WD
    PEDIATRIC RESEARCH, 1974, 8 (04) : 414 - 414
  • [50] Epstein-Barr virus latent genes
    Kang, Myung-Soo
    Kieff, Elliott
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2015, 47 : e131 - e131